Richmond has far surpassed other CROs, which take many years to build a similarly substantial database of potential volunteers. Richmonds unparalleled and proactive recruitment strategy has taken just 17 months to achieve an outstanding 17,000 volunteers on the database.Richmonds huge success with volunteer recruitment speaks for itself, having started eight new studies on time, during August this year, which included a record 158 volunteers! This demonstrates the efficiency of Richmonds process and the dedication of its staff.The substantial database also holds a wide range of patient populations which ensures that Richmonds first-rate recruitment team continue to meet all recruitment targets – particularly those for special populations – while offering a standard of service unmatched by competitors – providing clients with an efficient, superior trial with quality driven results.Richmond Pharmacology has – according to third parties – by far the largest dedicated volunteer recruitment department of any Phase 1 CRO in the UK, meaning delivery of volunteer numbers is guaranteed within the quoted budget, at no extra cost to the clients.Richmond Pharmacology’s recruitment website, www.trials4us.co.uk is designed for volunteers and includes specific information, frequently asked questions and online registration.

Latest news

Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read more

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Events

JSCPT 2025

5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event